← Open Payments lookup

NPI 1528446499: Open Payments

NPI 1528446499. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$317 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $107 · 2025 $317

Food & beverage: $317
CompanyPaymentsAmount
Lilly USA, LLC4$83
Novo Nordisk Inc4$75
Exact Sciences Corporation3$53
Boston Scientific Corporation3$43
MILLICENT US INC1$23
Astellas Pharma US Inc1$21
Paratek Pharmaceuticals, Inc.1$21

Products named: KISUNLA, The Cologuard Plus Collection Kit, Infinion 16, Wegovy, Ozempic, INTRAROSA, Veozah, NUZYRA.